NCT00592527View on ClinicalTrials.gov

Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Trial Locations (5)

390009

Novo Nordisk Investigational Site, Ahmedabad

440012

Novo Nordisk Investigational Site, Nagpur

600010

Novo Nordisk Investigational Site, Chennai

682041

Novo Nordisk Investigational Site, Kochi

600-013

Novo Nordisk Investigational Site, Chennai

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY